Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CPEX Pharmaceuticals, Inc. | b78732e10vk.htm |
| EX-23.2 - EX-23.2 - CPEX Pharmaceuticals, Inc. | b78732exv23w2.htm |
| EX-31.2 - EX-31.2 - CPEX Pharmaceuticals, Inc. | b78732exv31w2.htm |
| EX-31.1 - EX-31.1 - CPEX Pharmaceuticals, Inc. | b78732exv31w1.htm |
| EX-10.11 - EX-10.11 - CPEX Pharmaceuticals, Inc. | b78732exv10w11.htm |
| EX-32.2 - EX-32.2 - CPEX Pharmaceuticals, Inc. | b78732exv32w2.htm |
| EX-32.1 - EX-32.1 - CPEX Pharmaceuticals, Inc. | b78732exv32w1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement Nos. 333-152040
and 333-160052 on Form S-8 of our report dated March 29, 2010, relating to the consolidated
financial statements of CPEX Pharmaceuticals, Inc, which appears in this Annual Report on Form 10-K
of CPEX Pharmaceuticals, Inc. for the year ended December 31, 2009.
/s/ BDO Seidman, LLP
Boston, Massachusetts
March 29, 2010